AbbVie Inc. · Q1 2024
ReportedApr 26, 2024
Period endedMar 31, 2024
Rule of 40+32
The quarter in short
Revenue $12.31B, up 0.7% year over year and down 13.9% on the quarter. EPS $0.77, up 492.3% year over year and 71.1% on the quarter. Free cash flow $3.85B, down 4.3% year over year and 15.4% on the quarter. Rule of 40 score +32.
Reported this quarter
Revenue
$12.31B
QoQ −13.9%
YoY +0.7%
EPS
$0.77
QoQ +71.1%
YoY +492.3%
Free Cash Flow
$3.85B
QoQ −15.4%
YoY −4.3%
Gross Margin
66.7%
QoQ −4.0 pp
YoY −0.7 pp
FCF Margin
31.3%
QoQ −0.6 pp
YoY −1.6 pp
P/E Ratio
50.4
QoQ −3.9%
YoY +49.2%
Each tile opens the full quarterly series. Download the numbers as CSV or JSON.
Sources & downloads
Company
Published by the company on the day of the release.
HTML
Earnings press release
Investor relations announcement
SEC filings
Filed with the SEC under CIK 1551152.
HTML
8-K results announcement
Filed Apr 26, 2024
HTM
Press release (EX-99.1)
Exhibit 99.1 to the 8-K
258 KB
HTML
Filing index
Every document in the 8-K submission
TXT
Complete submission
Raw archival text of the whole filing
HTML
10-Q quarterly report
Period ended Mar 31, 2024, filed May 3, 2024
ZIP
XBRL data bundle
Structured financial statements from the 10-Q
JSON
Company facts (XBRL)
Every figure ABBV has reported to the SEC
R40 data
The numbers shown on this page, as we hold them.
CSV
This quarter (CSV)
Reported metrics for Q1 2024, spreadsheet-ready
JSON
This quarter (JSON)
Metrics, dates and matched filings